$NHI

National Health Investors, Inc. (NHI) Stock Forecasts

Argus lowered its target price for National Health Investors (NHI) to $62, maintaining a HOLD rating. The company has medium industry, management, safety, and financial strength ratings, with low growth and value subratings.

Original reporting
Published Oct 7, 2026, 10:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 1:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$NHI
Bearish
medium confidence
Mentioned
$NHI · $WELL · $NNN · $OHI · $WPC
Relevance
5/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$NHIBearishMed
01

Why it matters

These adjustments reflect revised earnings expectations across the sector.

02

Market read

Rating and target changes may prompt short-term price adjustments in the REIT sector.

03

What to watch

Potential upside from upcoming lease renewals not reflected in target.

Relevance 5/10Novelty 5/10Timing: today

Background

Analyst rating and target price updates for several US REITs.

Company-level read

Ticker impact

$NHIBearishMedium confidence
Context

Analyst lowered NHI target price to $62.00 and kept rating at HOLD.

Expected impact

likely pressure as investors price in the lower target.

Evidence & confidence

Target price reduction without rating change suggests concerns about future earnings.

$WELLBearishMedium confidence
Context

Analyst lowered WELL target price to $248.00.

Expected impact

possible slight decline as market absorbs lower target.

Evidence & confidence

Target cut reflects revised expectations for the REIT.

$NNNBearishMedium confidence
Context

Analyst lowered NNN target price to $38.00.

Expected impact

likely modest downside.

Evidence & confidence

Analyst view downgrade signals weaker outlook.

$OHIBearishMedium confidence
Context

Analyst lowered OHI target price to $49.00.

Expected impact

potential modest pressure.

Evidence & confidence

Target cut reflects revised earnings expectations.

$WPCNeutralLow confidence
Context

Analyst changed WPC rating to HOLD.

Expected impact

likely limited movement.

Evidence & confidence

Hold rating without target change suggests status quo.

Market effects

May signal broader REIT valuation pressure.

Limited to US REIT investors.

Low global impact.

Counterpoint

Target cuts could be overreactions; fundamentals remain solid.

Key entities

  • National Health Investors

    US REIT focused on healthcare properties.

  • Welltower

    US REIT specializing in senior housing.

  • National Retail Properties

    US REIT owning retail properties.

  • Omega Healthcare Investors

    US REIT focused on senior housing.

  • Washington Prime Group

    US REIT owning shopping centers.

Related articles

$WELLHigh

What Is Behind The Move In Welltower Stock?

Welltower (WELL) stock fell 5.8% on October 27, 2026, after reporting Q3 results. Net income was $0.54 per share, missing estimates, while revenue exceeded expectations at $3.72B. Normalized FFO per share rose 24.6% YoY to $1.67, beating estimates. The company raised its full-year outlook midpoint to $6.50 per share. Peers also declined, with Ventas falling 4.7%. WELL stock is up 29.3% over the past year.

$WELLMedAI 8/10

Welltower Stock Slumps Despite $21B Buying Spree, Soaring Income

Welltower, the largest U.S. senior housing REIT, saw shares drop over 5% despite strong Q3 results and a $21B investment spree. Revenue and profit grew 38% and 47% YoY, but missed expectations. The company raised its net income and FFO forecasts, projecting 23% growth this year. Welltower's market cap remains the highest among REITs at $163.4B.

$WELLMedAI 8/10

Welltower Inc (WELL) (Q3 2026) Earnings Call Highlights: 38% Revenue Surge, Raised FFO

Welltower Inc (WELL) reported Q3 2026 revenue growth of 38% and adjusted EBITDA growth of 35%, raising its full-year FFO outlook to $6.50. The company highlighted strong same-store NOI growth and a robust investment pipeline, but noted macroeconomic risks and potential challenges from low-occupancy acquisitions. Management emphasized focus on existing portfolio optimization and operational excellence.

$WELLMed

‘Opportunity Is the Constraint’: Welltower Continues Senior Living Buying Spree in 3Q

Welltower (WELL) acquired $2.7B in senior living properties in 3Q 2026, totaling $21B in investments this year. CEO Shankh Mitra emphasized selective acquisitions, focusing on quality operators. The REIT reported $415M net operating income and FFO of $1.67 per share. Welltower's stock is down 5.8% to $226.72. The company expects more acquisition opportunities due to upcoming debt maturities in the senior living sector.